Minimally Invasive Glaucoma Surgery (MIGS) is a new advanced type of outpatient procedure for patients with mild to moderate glaucoma. The procedures increase glaucoma control and eliminate the need for a major surgical glaucoma procedure. There are many benefits to MIGS, including fast healing, minimal risk to patients and improved glaucoma control. MIGS are the first procedures of their kind, allowing patients to preserve their vision for a longer period of time.
The standard major surgical glaucoma procedures are very often effective at lowering eye pressure and preventing progression of glaucoma, but they also have potential complications and long recovery periods associated with them. MIGS have been developed in recent years to reduce some of the complications while yielding similar results.
Following MIGS, patients typically experience a decrease in the amount of glaucoma medication they require. The recovery from MIGS is usually faster than the recovery from traditional glaucoma surgery.
